Abiopharma

V2X Awarded $500 Million U.S. Air Force C-12 Sustainment Contract Following Proven Readiness Performance

VNET to Announce Unaudited Second Quarter 2026 Financial Results on August 18, 2026

HUB Cyber Security Ltd. Enters into Agreement to Sell the QPoint Group for Approximately US $8.7 Million to the Malam Team Group

Inuvo to Host Second Quarter 2026 Financial Results Conference Call on Tuesday, August 11th at 4:15 P.M. ET

Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy

ZenaTech Files Five Patents for ZenaDrone’s Acoustic Drone Solution for Wildfire Suppression, Positioning for Government, Emergency Management and Commercial Opportunities in Aerial Firefighting Expected to Grow to a $2.8 Billion Market by 2033

G. WILLI-FOOD INTERNATIONAL REPORTS THE RESULTS OF SECOND QUARTER 2026 WITH SIGNIFICANT IMPROVEMENTS WITH OPERATIONAL PROFIT PARAMETERS

Net Asset Value(s)

MARA Appoints Two New Independent Directors to Board

cash dividend distribution of approximately NIS 1.44 per ordinary share, record date n August 18, 2026 , payment on September 3, 2026

Sysco Reports Fiscal Fourth Quarter and Full Year 2026 Results; Issues FY27 Guidance of 9%-11% Adjusted EPS Growth

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

XBP Global Named a Major Player in the 2026 IDC MarketScape for Worldwide Mailroom Solutions and Services

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

Nuvation Bio Inc. - Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses